Clinical trial Recruiting at 1 site Interventional Ages 21 to 70

Regular CBD use and the body's response to acute stress

Official title: Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms

Run by University of Minnesota · NCT07069478 · Data updated 2026-11-12

This study will test whether adults who use cannabidiol (CBD) regularly have different physical and mood reactions to an acute stress test compared with adults who do not use CBD.

Quick facts

Study typeInterventional
Ages21 Years to 70 Years
SexAll
Enrollment125 (estimated)
SponsorUniversity of Minnesota
Academic / other
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedJune 16, 2025
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedJuly 22, 2026
Trial IDNCT07069478 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 21–70 who either use CBD daily/regularly or do not use CBD regularly and who can maintain a normal night-time sleep schedule are ideal candidates.

Probably not a fit

People with unstable major psychiatric or medical conditions, current illicit substance use (other than cannabis), self-reported pregnancy, or inability to follow pre-visit abstinence rules are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will compare psychobiological responses to an acute laboratory stressor between relatively healthy adults aged 21–70 who either use CBD regularly or do not. The protocol includes measurement of cardiovascular reactivity, hypothalamic-pituitary-adrenal (HPA) axis markers, and mood responses before, during, and after stress induction. Correlates of CBD use such as tobacco use and basic health screening will be collected to help interpret findings. Participants must attend visits at the University of Minnesota and follow pre-visit abstinence and sleep schedule instructions.

Why it matters

Potential benefit: If successful, the findings could clarify whether regular CBD use changes physiological or mood responses to stress and inform guidance for people using CBD for stress management.

How similar studies have gone: Some single-dose laboratory studies of CBD have reported reduced anxiety or altered stress markers, but evidence on effects of regular CBD use on physiological stress responses is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults who are relatively healthy and aged 21-70 years.
* Must keep a normal sleep schedule (sleep during nighttime, awake during daytime).
* Must either (1) use CBD daily/regularly or (2) not use CBD regularly.

Exclusion Criteria:

* Participated in previous acute stress studies that included a similar stress induction.
* Current, unstable: major psychiatric disorder or medical condition (e.g., uncontrolled hypertension above 160/100).
* Self-reported current pregnancy.
* Self-reported current use of illicit substances (other than cannabis).
* Non-compliance with instructions for study visit (abstinence from alcohol, caffeine, physical activity, etc.)
* Students of the principal researcher

Where it's running

  • University of Minnesota
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

  • Principal investigator: Mustafa al'Absi — University of Minnesota
  • Study coordinator: Stress and Resilience Research Labs
  • Email: umdbml@d.umn.edu
  • Phone: 2187268623

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.